by According to Precedence Research, during the forecast period of 2022 to 2030, the global non-oncology precision medicine market is estimated to develop at a compound annual growth rate (CAGR) of 9.98%. The global non-oncology precision medicine market was valued at USD 63.79 billion in 2021, and it is predicted to exceed USD 150.2 billion by 2030. The study investigates several elements and their consequences on the growth of the non-oncology precision medicine market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1798
This report focuses on non-oncology precision medicine market volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall non-oncology precision medicine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of non-oncology precision medicine, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of non-oncology precision medicine has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the non-oncology precision medicine market.
Some of the prominent players in the non-oncology precision medicine market include:
- Pfizer Inc.
- Qiagen Inc.
- Quest Diagnostics Inc.
- Medtronic
- Novartis
- Laboratory Corporation of America Holdings
- bioMérieux SA
- Abbott Laboratories
- F. Hoffmann-La Roche A
- Eli Lilly & Company
Ask Here For More Customization Study@ https://www.precedenceresearch.com/checkout/1798
Segments Covered in the Report
By Product Type
- Diagnostics
- Genetic Tests
- Biomarker Based Tests
- Others
- Therapeutics
By Application
- Oncology
- CNS
- Immunology
- Respiratory
- Infectious Diseases
- Respiratory Infections
- Gastrointestinal Infections
- Sexually Transmitted Infections
- Others
- Neurology
- Neurodegenerative Disorders
- Neuropsychiatric Disorders
- Others
- Cardiovascular
- Cardiac Myopathies and Arrhythmia
- Others
- Lifestyle and Endocrinology
- Gastroenterology
- Others
By End-use
- Hospitals
- Diagnostic Centers
- Research & Academic Institutes
- Others
By Ecosystem
- Applied Sciences
- Genomics
- By Technology
- Polymerase Chain Reaction (PCR)
- Precision Medicine Next-Generation Sequencing (PM NGS)
- Genome Editing
- Other Technologies
- Pharmacogenomics
- Other Applied Sciences
- Precision Diagnostics
- Molecular Diagnostics (MDx)
- Medical Imaging
- Digital Health and Information Technology
- Clinical Decision Support Systems (CDSS)
- Big Data Analytics
- IT Infrastructure
- Genomics Informatics
- In-Silico Informatics
- Mobile Health
- Precision Therapeutics
- Clinical Trials
- Cell Therapy
- Drug Discovery and Research
- Gene Therapy
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Non-Oncology Precision Medicine Market
5.1. COVID-19 Landscape: Non-Oncology Precision Medicine Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Non-Oncology Precision Medicine Market, By Product Type
8.1. Non-Oncology Precision Medicine Market, by Product Type, 2022-2030
8.1.1. Diagnostics
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Therapeutics
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Non-Oncology Precision Medicine Market, By Application
9.1. Non-Oncology Precision Medicine Market, by Application e, 2022-2030
9.1.1. Oncology
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. CNS
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Immunology
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Respiratory
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Infectious Diseases
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Neurology
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Cardiovascular
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Lifestyle and Endocrinology
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Gastroenterology
9.1.9.1. Market Revenue and Forecast (2017-2030)
9.1.10. Others
9.1.10.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Non-Oncology Precision Medicine Market, By End-use
10.1. Non-Oncology Precision Medicine Market, by End-use, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Diagnostic Centers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Research & Academic Institutes
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Non-Oncology Precision Medicine Market, By Ecosystem
11.1. Non-Oncology Precision Medicine Market, by Ecosystem, 2022-2030
11.1.1. Applied Sciences
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Precision Diagnostics
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Digital Health and Information Technology
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Precision Therapeutics
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Non-Oncology Precision Medicine Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.3. Market Revenue and Forecast, by End-use (2017-2030)
12.1.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.3. Market Revenue and Forecast, by End-use (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.3. Market Revenue and Forecast, by End-use (2017-2030)
12.2.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.3. Market Revenue and Forecast, by End-use (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.3. Market Revenue and Forecast, by End-use (2017-2030)
12.3.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.3. Market Revenue and Forecast, by End-use (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.3. Market Revenue and Forecast, by End-use (2017-2030)
12.4.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.3. Market Revenue and Forecast, by End-use (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.3. Market Revenue and Forecast, by End-use (2017-2030)
12.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.3. Market Revenue and Forecast, by End-use (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)
Chapter 13. Company Profiles
13.1. Pfizer Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Qiagen Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Quest Diagnostics Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Medtronic
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Novartis
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Laboratory Corporation of America Holdings
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. bioMérieux SA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Abbott Laboratories
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. F. Hoffmann-La Roche A
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Eli Lilly & Company
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1798
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
